1Mandel S. Changes Insulin - like growth factor - I ( IGF - I ), IGF - binding - protein - 3, growth hormone - binding protein, e- rythroeyte IGF - I receptor and growth rate during GH treatment [ J ]. Clin Endocrinol Metab, 1995,80 ( 1 ) : 190 - 194. 被引量：1
2Clemmons DR, Moses AC, Mckay M J, et al. The combination of in- sulin - like growth factor I and insulin - like growth factor - bind- ing- pritein- 3 reduces insulin requirements in insulin -depend- ent typel diabeter: evi - denceforin vivo biological activity [ J ]. Clin Endocfinol Metab ,2000,85 (4) : 1518 - 1524. 被引量：1
3RubiniM, HongoA, Dambrosio C, et al. The IGF - 1 receptor inmi- togenesis and transformation of mouse embryo cells: role of receptor number[J]. Exp CellRes, 1997,230(2) : 284 -292. 被引量：1
4Burroughs KD, Howe SR, Okubo Y. Dysregulation of IGF - I signa- ling in uterine leiomyoma[ J ]. Endocrino1,2002,172 ( 1 ) :83 - 93. 被引量：1
5Matsuo H, Gao Z, Wang Y. Up - regulation by IGF - I of prelifera- tin cell nuclear antigen and Bcl -2 protein expression in human u- terine Leiomyoma cells [ J ]. Clin Endocfinol Metab, 2001,86 ( 11 ) :5593 -5599. 被引量：1
6Kuttan R, Bhanumathy P, Nirmala K, et al. Potential antieaneer activity of turmerie(Curccmalonga) [ J ]. Cancer Lett, 1985,29 (2) :197 -204. 被引量：1
